We are live on ! Find out more
AC

Aristeia Capital Portfolio holdings

AUM $4.82B
1-Year Est. Return 24.94%
This Fund
S&P 500
This Quarter Est. Return
+2.85%
1 Year Est. Return
+24.94%
3 Year Est. Return
+78.83%
5 Year Est. Return
+102.49%
10 Year Est. Return
+757.46%
AUM
$5.65B
AUM Growth
+$1.93B
Cap. Flow
+$778M
Cap. Flow %
13.77%
Top 10 Hldgs %
84.07%
Holding
282
New
35
Increased
16
Reduced
22
Closed
59

Top Buys

Rank Stock Value
1
CMI icon
Cummins
CMI
+$25.3M
2
FYBR
Frontier Communications
FYBR
+$18.5M
3
BATRK icon
Atlanta Braves Holdings Series B
BATRK
+$17.7M
4
LSXMA
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
+$17.6M
5
LSXMK
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
+$9.84M

Top Sells

Rank Stock Value
1
DEN
Denbury Inc.
DEN
+$61.1M
2
AAC
Ares Acquisition Corporation
AAC
+$36.6M
3
TRTL
TortoiseEcofin Acquisition Corp. III
TRTL
+$23.7M
4
LBRDK icon
Liberty Broadband Class C
LBRDK
+$21.7M
5
CDAQ
Compass Digital Acquisition Corp. Class A Ordinary Shares
CDAQ
+$19.1M

Sector Composition

Rank Sector Weight
1 Communication Services 13.21%
2 Consumer Discretionary 3.54%
3 Financials 3.41%
4 Industrials 0.68%
5 Technology 0.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FLFVR
101
DELISTED
Feutune Light Acquisition Corporation Right
FLFVR
$38.3K ﹤0.01%
450,000
– –
BNZIW icon
102
Banzai International Warrant
BNZIW
$126K
$36.5K ﹤0.01%
847,739
– –
MDAIW icon
103
Spectral AI Warrants
MDAIW
$5.67M
$32.9K ﹤0.01%
140,656
– –
BZFDW icon
104
BuzzFeed Inc Warrant
BZFDW
$905K
$32.3K ﹤0.01%
765,011
– –
CLDI.WS
105
DELISTED
Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00
CLDI.WS
$31.9K ﹤0.01%
494,400
– –
AEON.WS
106
DELISTED
AEON Biopharma Inc
AEON.WS
$31.3K ﹤0.01%
358,333
– –
BETRW icon
107
Better Home & Finance Warrant
BETRW
$2.28M
$30.1K ﹤0.01%
197,380
– –
ENGNW icon
108
enGene Therapeutics Warrants
ENGNW
$28.3K ﹤0.01%
+24,045
New +$18.5K
SVIIW
109
DELISTED
Spring Valley Acquisition Corp II Warrant
SVIIW
$27.1K ﹤0.01%
299,100
– –
SZZLW
110
DELISTED
Sizzle Acquisition Corp. Warrant
SZZLW
$25.9K ﹤0.01%
225,000
– –
COCHW icon
111
Envoy Medical Warrant
COCHW
$465K
$25.6K ﹤0.01%
1,089,889
– –
XBPEW
112
XBP Europe Holdings Warrant
XBPEW
$25.4K ﹤0.01%
468,502
+118,222
+34% +$13K
HYAC.WS
113
DELISTED
Haymaker Acquisition Corp 4 Warrants
HYAC.WS
$24.8K ﹤0.01%
149,999
– –
ECXWW
114
ECARX Holdings Warrants
ECXWW
$24.3K ﹤0.01%
784,974
– –
TGAAW
115
DELISTED
Target Global Acquisition I Corp. Warrant
TGAAW
$23.3K ﹤0.01%
155,383
– –
BSLKW
116
DELISTED
Bolt Projects Holdings Warrant
BSLKW
$23K ﹤0.01%
165,340
+98,674
+148% +$11.7K
GCTS.WS
117
GCT Semiconductor Holding Warrants
GCTS.WS
$14.3M
$22.5K ﹤0.01%
250,000
– –
ATEK.WS
118
DELISTED
Athena Technology Acquisition Corp. II Redeemable Warrants
ATEK.WS
$22.5K ﹤0.01%
749,891
– –
JWSM.WS
119
DELISTED
Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
JWSM.WS
$21.8K ﹤0.01%
561,895
– –
PHYT.WS
120
DELISTED
Pyrophyte Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
PHYT.WS
$21.8K ﹤0.01%
+325,000
New +$24.4K
PSFE.WS
121
DELISTED
Paysafe Ltd Warrants
PSFE.WS
$21.6K ﹤0.01%
819,649
– –
MNTN.WS
122
DELISTED
Everest Consolidator Acquisition Corporation Warrants, each whole warrant exercisable for one share of Class A Common Stock, at an exercise price of $11.50
MNTN.WS
$21.4K ﹤0.01%
171,280
-3,720
-2% -$484
ALCYW
123
DELISTED
Alchemy Investments Acquisition Corp 1 Warrants
ALCYW
$20.9K ﹤0.01%
113,216
– –
FLDDW
124
Fold Holdings Warrant
FLDDW
$1.06M
$20.6K ﹤0.01%
374,801
– –
AIRJW
125
AirJoule Technologies Warrant
AIRJW
$61.4M
$20.6K ﹤0.01%
750,000
– –
3 4
5
6 7

Similar funds

TPCW
TD Private Client Wealth New York $4.82B AUM 15.21% 1-Year Est. Return
JSTA
Japan Science & Technology Agency Tokyo, Japan $4.81B AUM 4.62% 1-Year Est. Return
BMO
Beck Mack & Oliver New York $4.85B AUM 9.66% 1-Year Est. Return
GAM
Generali Asset Management Trieste, Italy $4.79B AUM 26.21% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
MCCA
Mill Creek Capital Advisors Conshohocken, Pennsylvania $4.87B AUM 17.69% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return

Aristeia Capital's Q4 2023 Portfolio in Review

As of Q4 2023, Aristeia Capital held 282 positions worth $5.65B, up 52% from $3.72B the previous quarter. Its ten largest holdings account for 84% of the portfolio.

Aristeia Capital deployed $778M of net new capital in Q4 2023, opening 35 new positions and adding to 16 existing holdings. Its largest new stake was Cummins: 111,484 shares worth $26.7M.

By sector, the portfolio is most concentrated in Communication Services at 13% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was TortoiseEcofin Acquisition Corp. III, an estimated $23.7M trimmed.

  • Aristeia Capital's largest Q4 2023 buy was Cummins: 111,484 shares worth $26.7M.
  • Aristeia Capital added most to Frontier Communications in Q4 2023, an estimated $18.5M increase.
  • Aristeia Capital's biggest Q4 2023 reduction was TortoiseEcofin Acquisition Corp. III, cutting an estimated $23.7M.
  • Aristeia Capital fully exited Denbury Inc. in Q4 2023, selling an estimated $61.1M.
  • Aristeia Capital's ten largest holdings make up 84% of its $5.65B portfolio in Q4 2023.
  • Aristeia Capital opened 35 new positions and closed 59 in Q4 2023.
  • Aristeia Capital's portfolio value rose 52% quarter-over-quarter to $5.65B.

Based on Aristeia Capital's 13F filing for Q4 2023, filed 14 Feb 2024.